New concepts in liver regeneration

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue SUPPL. 1, 2011, Pages 203-212

  Riehle, Kimberly J ^a   Dan, Yock Y ^c   Campbell, Jean S ^b   Fausto, Nelson ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Hepatocytes; Partial hepatectomy; Progenitor cells

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR;

CELL PROLIFERATION; CLINICAL TRIAL; HUMAN; LIVER CELL; LIVER INJURY; LIVER REGENERATION; LIVER RESECTION; PRIORITY JOURNAL; REVIEW; STEM CELL NICHE; STEM CELL TRANSPLANTATION;

EID: 78650774491     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06539.x     Document Type: Review

References (126)

1. Taub R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell. Biol. 2004; 5: 836-47.
2. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006; 43 (2 Suppl. 1): S45-53.
3. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004; 39: 1477-87.
4. Fitzpatrick E, Mitry RR, Dhawan A. Human hepatocyte transplantation: state of the art. J. Intern. Med. 2009; 266: 339-57.
5. Bucher NL, Glinos AD. The effect of age on regeneration of rat liver. Cancer Res. 1950; 10: 324-32.
6. Bucher NL. Regeneration of Mammalian Liver. Int. Rev. Cytol. 1963; 15: 245-300.
7. Bucher NL, Weir GC. Insulin, glucagon, liver regeneration, and DNA synthesis. Metabolism. 1976; 25 (11 Suppl. 1): 1423-5.
8. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 1441-6.
9. Anders RA, Subudhi SK, Wang J, Pfeffer K, Fu YX. Contribution of the lymphotoxin beta receptor to liver regeneration. J. Immunol. 2005; 175: 1295-300.
10. Tumanov AV, Koroleva EP, Christiansen PA et al. T cell-derived lymphotoxin regulates liver regeneration. Gastroenterology. 2009; 136: 694-704 e4.
11. Campbell JS, Riehle KJ, Brooling JT, Bauer RL, Mitchell C, Fausto N. Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4. J. Immunol. 2006; 176: 2522-8.
12. Seki E, Tsutsui H, Iimuro Y et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology. 2005; 41: 443-50.
13. Strey CW, Markiewski M, Mastellos D et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 2003; 198: 913-23.
14. Cressman DE, Greenbaum LE, DeAngelis RA et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996; 274: 1379-83.
15. Cressman DE, Diamond RH, Taub R. Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology. 1995; 21: 1443-9.
16. Malato Y, Sander LE, Liedtke C et al. Hepatocyte-specific inhibitor-of-kappaB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration. Hepatology. 2008; 47: 2036-50.
17. Francavilla A, Ove P, Polimeno L, Sciascia C, Coetzee ML, Starzl TE. Epidermal growth factor and proliferation in rat hepatocytes in primary culture isolated at different times after partial hepatectomy. Cancer Res. 1986; 46: 1318-23.
18. Raper SE, Burwen SJ, Barker ME, Jones AL. Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology. 1987; 92 (5 Pt 1): 1243-50.
19. Russell WE, Kaufmann WK, Sitaric S, Luetteke NC, Lee DC. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Mol. Carcinog. 1996; 15: 183-9.
20. Mead JE, Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 1558-62.
21. Berasain C, Garcia-Trevijano ER, Castillo J et al. Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology. 2005; 128: 424-32.
22. Kiso S, Kawata S, Tamura S et al. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology. 1995; 22: 1584-90.
23. Mitchell C, Nivison M, Jackson LF et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J. Biol. Chem. 2005; 280: 2562-8.
24. Paranjpe S, Bowen WC, Tseng GC, Luo JH, Orr A, Michalopoulos GK. RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats. Am. J. Pathol. 2010; 176: 2669-81.
25. Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc. Natl. Acad. Sci. U.S.A. 2007; 104: 17081-6.
26. Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C. Met provides essential signals for liver regeneration. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 10608-13.
27. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 4477-82.
28. Paranjpe S, Bowen WC, Bell AW, Nejak-Bowen K, Luo JH, Michalopoulos GK. Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology. 2007; 45: 1471-7.
29. Factor VM, Seo D, Ishikawa T et al. Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice. PLoS One. 2010; 5: pii: 312739.
30. Mohammed FF, Pennington CJ, Kassiri Z et al. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology. 2005; 41: 857-67.
31. Mohammed FF, Smookler DS, Taylor SE et al. Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat. Genet. 2004; 36: 969-77.
32. Haga S, Ozaki M, Inoue H et al. The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation. Hepatology. 2009; 49: 204-14.
33. Haga S, Ogawa W, Inoue H et al. Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J. Hepatol. 2005; 43: 799-807.
34. Mullany LK, Nelsen CJ, Hanse EA et al. Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest. J. Biol. Chem. 2007; 282: 21244-52.
35. Volarevic S, Stewart MJ, Ledermann B et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science. 2000; 288: 2045-7.
36. Stoick-Cooper CL, Weidinger G, Riehle KJ et al. Distinct Wnt signaling pathways have opposing roles in appendage regeneration. Development. 2007; 134: 479-89.
37. Apte U, Thompson MD, Cui S, Liu B, Cieply B, Monga SP. Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology. 2008; 47: 288-95.
38. Hu M, Kurobe M, Jeong YJ et al. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology. 2007; 133: 1579-91.
39. Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology. 2006; 131: 1561-72.
40. Nejak-Bowen KN, Thompson MD, Singh S et al. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin. Hepatology. 2010; 51: 1603-13.
41. Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 2004; 22: 503-29.
42. Campbell JS, Prichard L, Schaper F et al. Expression of suppressors of cytokine signaling during liver regeneration. J. Clin. Invest. 2001; 107: 1285-92.
43. Riehle KJ, Campbell JS, McMahan RS et al. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J. Exp. Med. 2008; 205: 91-103.
44. White P, Brestelli JE, Kaestner KH, Greenbaum LE. Identification of transcriptional networks during liver regeneration. J. Biol. Chem. 2005; 280: 3715-22.
45. Li J, Campbell JS, Mitchell C et al. Relationships between deficits in tissue mass and transcriptional programs after partial hepatectomy in mice. Am. J. Pathol. 2009; 175: 947-57.
46. Chitwood DH, Timmermans MC. Small RNAs are on the move. Nature. 2010; 467: 415-9.
47. Song G, Sharma AD, Roll GR et al. MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology. 2010; 51: 1735-43.
48. Marquez RT, Wendlandt E, Galle CS, Keck K, McCaffrey AP. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 2010; 298: G535-41.
49. Duncan AW, Taylor MH, Hickey RD et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature. 2010; 467: 707-10.
50. Lesurtel M, Graf R, Aleil B et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006; 312: 104-7.
51. Liu B, Bell AW, Paranjpe S et al. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice. Hepatology. 2010; 52: 1060-7.
52. Apte U, Gkretsi V, Bowen WC et al. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology. 2009; 50: 844-51.
53. Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res. 1956; 16: 142-8.
54. Lazaro CA, Rhim JA, Yamada Y, Fausto N. Generation of hepatocytes from oval cell precursors in culture. Cancer Res. 1998; 58: 5514-22.
55. Dunsford HA, Karnasuta C, Hunt JM, Sell S. Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Res. 1989; 49: 4894-900.
56. Theise ND, Saxena R, Portmann BC et al. The canals of Hering and hepatic stem cells in humans. Hepatology. 1999; 30: 1425-33.
57. Roskams T, Yang SQ, Koteish A et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am. J. Pathol. 2003; 163: 1301-11.
58. Roskams TA, Theise ND, Balabaud C et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology. 2004; 39: 1739-45.
59. Zajicek G, Oren R, Weinreb M, Jr. The streaming liver. Liver. 1985; 5: 293-300.
60. Fellous TG, Islam S, Tadrous PJ et al. Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology. 2009; 49: 1655-63.
61. Lin WR, Lim SN, McDonald SA et al. The histogenesis of regenerative nodules in human liver cirrhosis. Hepatology. 2010; 51: 1017-26.
62. Kuwahara R, Kofman AV, Landis CS, Swenson ES, Barendswaard E, Theise ND. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology. 2008; 47: 1994-2002.
63. Shinozuka H, Lombardi B, Sell S, Iammarino RM. Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a choline-deficient diet. Cancer Res. 1978; 38: 1092-8.
64. Yovchev MI, Grozdanov PN, Zhou H, Racherla H, Guha C, Dabeva MD. Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology. 2008; 47: 636-47.
65. Faktor VM, Engel'gardt NV, Iazova AK, Lazareva MN, Poltoranina VS, Rudinskaia TD. [Common antigens of oval cells and cholangiocytes in the mouse. Their detection by using monoclonal antibodies]. Ontogenez. 1990; 21: 625-32.
66. Petersen BE, Grossbard B, Hatch H, Pi L, Deng J, Scott EW. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology. 2003; 37: 632-40.
67. Dorrell C, Erker L, Lanxon-Cookson KM et al. Surface markers for the murine oval cell response. Hepatology. 2008; 48: 1282-91.
68. Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology. 2001; 120: 534-44.
69. Dezso K, Jelnes P, Laszlo V et al. Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration. Am. J. Pathol. 2007; 171: 1529-37.
70. Jelnes P, Santoni-Rugiu E, Rasmussen M et al. Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regeneration. Hepatology. 2007; 45: 1462-70.
71. Dan YY, Yeoh GC. Liver stem cells: a scientific and clinical perspective. J. Gastroenterol. Hepatol. 2008; 23: 687-98.
72. Inada M, Follenzi A, Cheng K et al. Phenotype reversion in fetal human liver epithelial cells identifies the role of an intermediate meso-endodermal stage before hepatic maturation. J. Cell Sci. 2008; 121 (Pt 7): 1002-13.
73. Schmelzer E, Zhang L, Bruce A et al. Human hepatic stem cells from fetal and postnatal donors. J. Exp. Med. 2007; 204: 1973-87.
74. Schmelzer E, Wauthier E, Reid LM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells. 2006; 24: 1852-8.
75. Zhang L, Theise N, Chua M, Reid LM. The stem cell niche of human livers: symmetry between development and regeneration. Hepatology. 2008; 48: 1598-607.
76. Alison MR, Poulsom R, Jeffery R et al. Hepatocytes from non-hepatic adult stem cells. Nature. 2000; 406: 257.
77. Nonome K, Li XK, Takahara T et al. Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model. Am. J. Physiol. Gastrointest. Liver Physiol. 2005; 289: G1091-9.
78. Sensken S, Waclawczyk S, Knaupp AS et al. In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy. 2007; 9: 362-78.
79. Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000; 6: 1229-34.
80. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999; 284: 1168-70.
81. Willenbring H, Bailey AS, Foster M et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat. Med. 2004; 10: 744-8.
82. Harris RG, Herzog EL, Bruscia EM, Grove JE, Van Arnam JS, Krause DS. Lack of a fusion requirement for development of bone marrow-derived epithelia. Science. 2004; 305: 90-3.
83. Cantz T, Sharma AD, Jochheim-Richter A et al. Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant. 2004; 13: 659-66.
84. Menthena A, Deb N, Oertel M et al. Bone marrow progenitors are not the source of expanding oval cells in injured liver. Stem Cells. 2004; 22: 1049-61.
85. Dan YY, Riehle KJ, Lazaro C et al. Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 9912-7.
86. Aurich I, Mueller LP, Aurich H et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut. 2007; 56: 405-15.
87. Banas A, Teratani T, Yamamoto Y et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 2007; 46: 219-28.
88. Lee KD, Kuo TK, Whang-Peng J et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004; 40: 1275-84.
89. Sicklick JK, Choi SS, Bustamante M et al. Evidence for epithelial-mesenchymal transitions in adult liver cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 291: G575-83.
90. Yang L, Jung Y, Omenetti A et al. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells. 2008; 26: 2104-13.
91. Choi SS, Diehl AM. Epithelial-to-mesenchymal transitions in the liver. Hepatology. 2009; 50: 2007-13.
92. Syn WK, Jung Y, Omenetti A et al. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology. 2009; 137: 1478-88 e8.
93. Scholten D, Osterreicher CH, Scholten A et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology. 2010; 139: 987-98.
94. Taura K, Miura K, Iwaisako K et al. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology. 2010; 51: 1027-36.
95. Wells RG. The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow? Hepatology. 2010; 51: 737-40.
96. Popov Y, Schuppan D. Epithelial-to-mesenchymal transition in liver fibrosis: dead or alive? Gastroenterology. 2010; 139: 722-5.
97. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am. J. Pathol. 1999; 154: 537-41.
98. Roskams T. Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus. J. Hepatol. 2003; 39: 431-4.
99. Zhou H, Rogler LE, Teperman L, Morgan G, Rogler CE. Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology. 2007; 45: 716-24.
100. Bird TG, Lorenzini S, Forbes SJ. Activation of stem cells in hepatic diseases. Cell Tissue Res. 2008; 331: 283-300.
101. Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin. Cell Dev. Biol. 2002; 13: 389-96.
102. Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic "progenitor cells" correlates with parenchymal inflammation in chronic viral hepatitis: can "progenitor cells" migrate? J. Pathol. 2000; 192: 373-8.
103. Katoonizadeh A, Nevens F, Verslype C, Pirenne J, Roskams T. Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int. 2006; 26: 1225-33.
104. Evarts RP, Nagy P, Marsden E, Thorgeirsson SS. A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis. 1987; 8: 1737-40.
105. Suzuki A, Sekiya S, Onishi M et al. Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology. 2008; 48: 1964-78.
106. Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. The origin and liver repopulating capacity of murine oval cells. Proc. Natl. Acad. Sci. U.S.A. 2003; 100 (Suppl. 1): 11881-8.
107. Gaudio E, Carpino G, Cardinale V, Franchitto A, Onori P, Alvaro D. New insights into liver stem cells. Dig. Liver Dis. 2009; 41: 455-62.
108. Moore KA, Lemischka IR. Stem cells and their niches. Science. 2006; 311: 1880-5.
109. Wang Y, Yao HL, Cui CB et al. Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates. Hepatology. 2010; 52: 1443-54.
110. Duncan AW, Dorrell C, Grompe M. Stem cells and liver regeneration. Gastroenterology. 2009; 137: 466-81.
111. Erker L, Grompe M. Signaling networks in hepatic oval cell activation. Stem Cell Res. 2007; 1: 90-102.
112. Jakubowski A, Ambrose C, Parr M et al. TWEAK induces liver progenitor cell proliferation. J. Clin. Invest. 2005; 115: 2330-40.
113. Benhamouche S, Curto M, Saotome I et al. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev. 2010; 24: 1718-30.
114. Sackett SD, Li Z, Hurtt R et al. Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology. 2009; 49: 920-9.
115. Fleig SV, Choi SS, Yang L et al. Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice. Lab. Invest. 2007; 87: 1227-39.
116. Jung Y, Brown KD, Witek RP et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology. 2008; 134: 1532-43.
117. Van Hul NK, Abarca-Quinones J, Sempoux C, Horsmans Y, Leclercq IA. Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology. 2009; 49: 1625-35.
118. Kisseleva T, Gigante E, Brenner DA. Recent advances in liver stem cell therapy. Curr. Opin. Gastroenterol. 2010; 26: 395-402.
119. Basma H, Soto-Gutierrez A, Yannam GR et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology. 2009; 136: 990-9.
120. Song Z, Cai J, Liu Y et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 2009; 19: 1233-42.
121. Malhi H, Irani AN, Gagandeep S, Gupta S. Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes. J. Cell Sci. 2002; 115 (Pt 13): 2679-88.
122. Espejel S, Roll GR, McLaughlin KJ et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J. Clin. Invest. 2010; 120: 3120-6.
123. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin. Liver Dis. 1999; 19: 39-48.
124. Habibullah CM, Syed IH, Qamar A, Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation. 1994; 58: 951-2.
125. am Esch JS, 2nd, Knoefel WT, Klein M et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005; 23: 463-70.
126. Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology. 2008; 135: 438-50.